Pulmonary hypertension in pediatric heart transplantation

Progress in Pediatric Cardiology

Volumn 11, Issue 2, 2000, Pages 131-136

  Shaddy, Robert E ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Heart transplantation; Pediatrics; Pulmonary hypertension

Indexed keywords

DOBUTAMINE; ENOXIMONE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN E1;

CONGESTIVE HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; TREATMENT INDICATION;

EID: 0034213516     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(00)00040-0     Document Type: Article

References (67)

1. Bourge R.C., Naftel D.C., Costanzo-Nordin M.R. et al. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant. 12:1993;549-562.
2. Sarris G.E., Moore K.A., Schroeder J.S. et al. Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg. 108:1994;240-252.
3. Bando K., Konishi H., Komatsu K. et al. Improved survival following pediatric cardiac transplantation in high-risk patients. Circulation. 88:1993;II218-II223.
4. Fukushima N., Gundry S.R., Razzouk A.J., Bailey L.L. Risk factors for graft failure associated with pulmonary hypertension after pediatric heart transplantation. J Thorac Cardiovasc Surg. 107:1994;985-989.
5. Carrier M., Rivard M., Latter D., Kostuk W. Predictors of early mortality after heart transplantation: the Canadian transplant experience from 1981 to 1992. The CASCADE Investigators. Canadian Study of Cardiac Transplant Atherosclerosis Determinants. Can J Cardiol. 14:1998;703-707.
6. Erickson K.W., Costanzo-Nordin M.R., O'Sullivan E.J. et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant. 9:1990;526-537.
7. Vouhe P.R., Tamisier D., Leca F. et al. Heart transplantation in children: risk factors of early and late mortality. Eur J Cardiothorac Surg. 5:1991;176-180.
8. McCarthy J.F., McCarthy P.M., Massad M.G. et al. Risk factors for death after heart transplantation: does a single- center experience correlate with multicenter registries? Ann Thorac Surg. 65:1998;1574-1579.
9. Costard-Jackle A., Hill I., Schroeder J.S., Fowler M.B. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation. 84:1991;III329-III337.
10. Kirklin J.K., Naftel D.C., Kirklin J.W., Blackstone E.H., White-Williams C., Bourge R.C. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 7:1988;331-336.
11. Murali S., Kormos R.L., Uretsky B.F. et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J. 126:1993;896-904.
12. Costard-Jackle A., Fowler M.B. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 19:1992;48-54.
13. Shaddy R.E., Naftel D.C., Kirklin J.K. et al. Outcome of cardiac transplantation in children. Survival in a contemporary multi-institutional experience. Pediatric Heart Transplant Study. Circulation. 94:1996;II69-II73.
14. Webber S.A., Fricker F.J., Michaels M. et al. Orthotopic heart transplantation in children with congenital heart disease. Ann Thorac Surg. 58:1994;1664-1669.
15. Adatia I., Perry S., Landzberg M., Moore P., Thompson J.E., Wessel D.L. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol. 25:1995;1656-1664.
16. Boffa G.M., Razzolini R., Grassi G. et al. Pulmonary vascular resistance variation over time in candidates for heart transplantation. Am J Cardiol. 73:1994;414-415.
17. Grant S.C., Levy R.D., Brooks N.H. Fall in pulmonary vascular resistance in patients awaiting heart transplantation. Br Heart J. 68:1992;365-368.
18. Stein J.H., Neumann A., Preston L.M. et al. Echocardiography for hemodynamic assessment of patients with advanced heart failure and potential heart transplant recipients. J Am Coll Cardiol. 30:1997;1765-1772.
19. Bolling S.F., Deeb G.M., Crowley D.C., Badellino M.M., Bove E.L. Prolonged amrinone therapy prior to orthotopic cardiac transplantation in patients with pulmonary hypertension. Transplant Proc. 20:1988;753-756.
20. Deeb G.M., Bolling S.F., Guynn T.P., Nicklas J.M. Amrinone versus conventional therapy in pulmonary hypertensive patients awaiting cardiac transplantation. Ann Thorac Surg. 48:1989;665-669.
21. Simonsen S., Molstad P., Geiran O., Froysaker T. Heart transplantation in patients with severe pulmonary hypertension and increased pulmonary vascular resistance. Scand J Thorac Cardiovasc Surg. 24:1990;161-164.
22. Chau E.M., Bailey K.R., Mahoney D.W. et al. Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year. Circulation. 94:1996;II267-II272.
23. Bundgaard H., Boesgaard S., Mortensen S.A., Arendrup H., Aldershvile J. Effect of nitroglycerin in patients with increased pulmonary vascular resistance undergoing cardiac transplantation. Scand Cardiovasc J. 31:1997;339-342.
24. Levine T.B., Levine A.B., Goldberg A.D. et al. Acute reversibility of pulmonary hypertension predicts neither long-term hemodynamic response nor outcome in patients awaiting heart transplantation. Am J Cardiol. 79:1997;105-106.
25. Muikku O., Hynynen M., Salmenpera M., Nieminen M.S. Pulmonary vascular effects of nitroglycerin and isosorbide dinitrate in patients with end-stage cardiomyopathies. Acta Anaesthesiol Scand. 40:1996;909-912.
26. 1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension [see comments]. J Heart Lung Transplant. 11:1992;716-723.
27. 1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation. J Heart Lung Transplant. 12:1993;173-178.
28. Givertz M.M., Hare J.M., Loh E., Gauthier D.F., Colucci W.S. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol. 28:1996;1775-1780.
29. Murali S., Uretsky B.F., Reddy P.S., Tokarczyk T.R., Betschart A.R. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents. Am Heart J. 122:1991;1375-1381.
30. Kieler-Jensen N., Ricksten S.E., Stenqvist O. et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant. 13:1994;366-375.
31. Haraldsson A., Kieler-Jensen N., Nathorst-Westfelt U., Bergh C.H., Ricksten S.E. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest. 114:1998;780-786.
32. Tamisier D., Vouhe P., Le Bidois J., Mauriat P., Khoury W., Leca F. Donor-recipient size matching in pediatric heart transplantation: a word of caution about small grafts. J Heart Lung Transplant. 15:1996;190-195.
33. Yeoh T.K., Frist W.H., Lagerstrom C., Kasper E.K., Groves J., Merrill W. Relationship of cardiac allograft size and pulmonary vascular resistance to long-term cardiopulmonary function. J Heart Lung Transplant. 11:1992;1168-1176.
34. Kawaguchi A., Gandjbakhch I., Pavie A. et al. Cardiac transplant recipients with preoperative pulmonary hypertension. Evolution of pulmonary hemodynamics and surgical options. Circulation. 80:1989;III90-III96.
35. Costanzo-Nordin M.R., Liao Y.L., Grusk B.B. et al. Oversizing of donor hearts: beneficial or detrimental? J Heart Lung Transplant. 10:1991;717-730.
36. Haverich A., Hirt S.W., Wagenberth I., Luhmer I., Ziemer G., Kallfelz H.C. Thoracic organ transplantation in the paediatric age group. The Hannover experience. Eur J Pediatr. 151:1992;S65-S69.
37. Addonizio L.J. Cardiac transplantation in the pediatric patient. Prog Cardiovasc Dis. 33:1990;19-34.
38. Sarris G.E., Smith J.A., Bernstein D. et al. Pediatric cardiac transplantation. The Stanford experience. Circulation. 90:1994;II51-II55.
39. Addonizio L.J., Gersony W.M., Robbins R.C. et al. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation. 76:1987;V52-V55.
40. Zales V.R., Pahl E., Backer C.L., Crawford S., Mavroudis C., Benson D.W. Jr Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation. J Heart Lung Transplant. 12:1993;965-973.
41. Gajarski R.J., Towbin J.A., Bricker J.T. et al. Intermediate follow-up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. J Am Coll Cardiol. 23:1994;1682-1687.
42. Cooper M.M., Fuzesi L., Addonizio L.J., Hsu D.T., Smith C.R., Rose E.A. Pediatric heart transplantation after operations involving the pulmonary arteries. J Thorac Cardiovasc Surg. 102:1991;386-395.
43. Hsu D.T., Quaegebeur J.M., Michler R.E. et al. Heart transplantation in children with congenital heart disease. J Am Coll Cardiol. 26:1995;743-749.
44. Shah A.S., Michler R.E. Successful heart transplantation with acquired pulmonary artery atresia. Ann Thorac Surg. 59:1995;1557-1559.
45. Boucek M.M., Mathis C.M., Razzouk A. et al. Indications and contraindications for heart transplantation in infancy. J Heart Lung Transplant. 12:1993;S154-S158.
46. Canter C.E., Moorehead S., Huddleston C.B., Spray T.L. Restrictive atrial septal communication as a determinant of outcome of cardiac transplantation for hypoplastic left heart syndrome. Circulation. 88:1993;II456-II460.
47. Denfield S.W., Rosenthal G., Gajarski R.J. et al. Restrictive cardiomyopathies in childhood. Etiologies and natural history. Tex Heart Inst J. 24:1997;38-44.
48. Hsu D.T., Addonizio L.J., Hordof A.J., Gersony W.M. Acute pulmonary embolism in pediatric patients awaiting heart transplantation [see comments]. J Am Coll Cardiol. 17:1991;1621-1625.
49. Lick S., Conti V. Thrombolysis with resolution of pulmonary hypertension in a heart transplant candidate. Chest. 115:1999;896-897.
50. Hunt S.A. Pulmonary hypertension in severe congestive heart failure: how important is it? J Heart Lung Transplant. 16:1997;S13-S15.
51. Oaks T.E., Rayburn B.K., Brown M.E., Kon N.D. Acquired cor triatriatum after orthotopic cardiac transplantation. Ann Thorac Surg. 59:1995;751-753.
52. Bhatia S.J., Kirshenbaum J.M., Shemin R.J. et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation. 76:1987;819-826.
53. Collins M.H., Darragh R.K., Caldwell R.L., Turrentine M.W., Brown J.W. Short-term survivors of pediatric heart transplantation: an autopsy study of their pulmonary vascular disease. J Heart Lung Transplant. 14:1995;1116-1125.
54. 1: an effective treatment of right heart failure after orthotopic heart transplantation. J Heart Transplant. 6:1987;348-351.
55. 1 requirement for heart transplantation. J Heart Lung Transplant. 11:1992;724-726.
56. 1 infusion for right ventricular failure after cardiac transplantation [see comments]. J Thorac Cardiovasc Surg. 103:1992;33-39.
57. 1, and sodium nitroprusside. J Heart Lung Transplant. 14:1995;436-443.
58. Bauer J., Dapper F., Demirakca S., Knothe C., Thul J., Hagel K.J. Perioperative management of pulmonary hypertension after heart transplantation in childhood. J Heart Lung Transplant. 16:1997;1238-1247.
59. Pascual J.M., Fiorelli A.I., Bellotti G.M., Stolf N.A., Jatene A.D. Prostacyclin in the management of pulmonary hypertension after heart transplantation. J Heart Transplant. 9:1990;644-651.
60. Kieler-Jensen N., Milocco I., Ricksten S.E. Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity. J Heart Lung Transplant. 12:1993;179-184.
61. Williams T.J., Salamonsen R.F., Snell G., Kaye D., Esmore D.S. Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J Heart Lung Transplant. 14:1995;419-423.
62. Auler Junior J.O., Carmona M.J., Bocchi E.A. et al. Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant. 15:1996;443-450.
63. Nakatani T., Radovancevic B., Frazier O.H. Right heart assist for acute right ventricular failure after orthotopic heart transplantation. ASAIO Trans. 33:1987;695-698.
64. Barzaghi N., Olivei M., Minzioni G., Degani A., Braschi A., Vigano M. ECMO and inhaled nitric oxide for cardiopulmonary failure after heart retransplantation. Ann Thorac Surg. 63:1997;533-535.
65. 1 and right ventricular assist. J Heart Transplant. 5:1986;317-321.
66. Kanter K.R., Pennington D.G., McBride L.R. et al. Mechanical circulatory assistance after heart transplantation. J Heart Transplant. 6:1987;150-154.
67. Day R.W., Barton A.J., Pysher T.J., Shaddy R.E. Pulmonary vascular resistance of children treated with nitrogen during early infancy. Ann Thorac Surg. 65:1998;1400-1404.